tag:blogger.com,1999:blog-5574479.post2087670053194445558..comments2024-03-29T13:59:42.629+00:00Comments on The IPKat: Falling off cliffs and clutching at straws: a new event on pharma patent extensionsVerónica RodrÃguez Arguijohttp://www.blogger.com/profile/05763207846940036921noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-5574479.post-1886937938666909472015-04-20T08:20:43.307+01:002015-04-20T08:20:43.307+01:00Jeremy; nice piece, as always.
Problem one is the...Jeremy; nice piece, as always.<br /><br />Problem one is the law of unintended consequences resulting in a law which says that you have to look at the contribution of the patent (or it is the research effort expended upon it?) to understand how far the SPC regulation goes and that this concept (nowhere stated in the body of the rules) decides whether you are entitled to an SPC or not.<br /><br />I am truly tired of saying it (or is it weary?) but this sort of legislating by judicial construct gives the CJEU and the "European project" a bad name, at a time when it could really do with a good one.<br /><br />I also think that part of the problem is the slightly disdainful way in which the CJEU treats certain of our patents judges. They deserve better.<br /><br />AshleyAshley Roughtonhttps://www.blogger.com/profile/11867564640201688641noreply@blogger.com